
The temporal mandibular joint (TMJ) is a bi-arthroidal hinge joint that allows daily complex movements in relation to mastication activities [1]. Cases involving disorders of the TMJ and related anatomical structures are defined as temporomandibular joint disorder (TMD) [2]. TMD occurs in a large number of people worldwide, with about 25% of adults presenting signs or symptoms [3]. In addition, it affects female at a rate of 1.5 to 2.5 times higher than male [4].
The etiology of TMD is multidimensional given that neurobiological, biomechanical, neuromuscular, and biopsychosocial factors can contribute to the disability [5]. In general, the cause of the pain caused by TMD is the disc displacement, and the disc displacement without reduction often has pain and mouth opening limitation [6,7]. In particular, pain with TMD is a decisive outcome even though it is not a pathologically direct cause, and affects the patient’s function and quality of life [8].
There are various physical therapy techniques for treatment of TMD. Treatment methods include psychotherapy, acupuncture, transcutaneous electrical nerve stimulation (TENS), soft tissue mobilization, low level laser (LLL), TMJ mobilization, and exercise therapy [9-13].
Among these various physical therapy techniques, TENS is well known as an effective and safe non-invasive method for pain control. TENS can reduce pain through increased blood flow by causing regular contraction of muscles, and is effective in pain control based on the gate control theory [14]. In addition, LLL, which is commonly used clinically for pain control for TMD, is widely used in musculoskeletal diseases. The mechanism of pain control of LLL has not been clearly identified, but it is known to decrease the permeability of nerve cell membranes by reducing edema due to an increase in microcirculation [15,16].
Many studies have been conducted on the treatment for TMD, which accounts for a large proportion of musculoskeletal disorders, but suggesting an effective method is limited. Therefore, the purpose of this study was to compare the therapeutic effects of TENS and LLL, which are mainly used in clinical practice, and apply a placebo to investigate each treatment effect.
This study was recruited from adults who complained of TMD symptoms on the bulletin board of Paul Block at Gwangju Health University. The inclusion criteria for participants was based on a simplified questionnaire for TMD of the American Academy of Orofacial Pain [17]. A simple questionnaire can be judged as TMD if at least one of the 10 items is positive. One symptom is considered as mild, two to 3 symptoms are considered as moderate, and four or more are considered to be severe. The exclusion criteria was patients with a history of recent trauma or other diseases in the area, people with cardiac arrhythmias or pacemakers, and those who were pregnant [18]. In this study, among potential participants, if pain occurred during left and right TMJ palpation when opening the mouth, the details and purpose of the study were informed, and if they agreed to participate, they were enrolled in the study. A total of 36 participants enrolled in this study where 12 participants were assigned to one of three groups according to a randomization method.
This study was approved by the Institutional Review Board of Sahmyook University (2-1040781-AB-N-01-2017 050HR) before the start of the experiment, and the randomized controlled trial was enrolled in the Clinical Research Information Service (KCT0002834).
The sample size was estimated as the amount of change in maximal mouth opening through LLL [18]. The calculated effect size f(V) was 0.37, and the power was 0.95 using G*Power 3.1 (Universität Kiel, Kiel, Germany), and when 3 groups and 3 measurements were taken, 27 participants were calculated. In consideration of dropouts (30%) during the experiment, 36 participants were finally recruited.
The participants were randomly assigned to TENS, LLL, or placebo groups using a Random Allocation Software (Isfahan University, Isfahan, Iran). Randomization was randomly generated with 3 blocks and 4 digits. The blindfolding of participants prevented them from knowing what treatment they were receiving by different intervention schedules.
In order to minimize errors that may occur in the procedure during the experiment, education on the research procedure was conducted before the intervention and evaluation. Each intervention was conducted over 2 weeks, 3 times a week, 10 minutes per session, for a total of 6 sessions.
For TENS, Intelect Advanced Color Combo with EMG (Chattanooga, Chattanooga, TN, USA) was used. The pad size was 20×20 mm, the waveform was symmetrical biphasic, the phase duration was 50
LLL is a non-invasive method for optical stimulation. The Laserneedle Touch (Laserneedle GmbH, Glienicke/Nordbahn, Germany) used in this study provided a continuous wave mode red light and 685 Nm that generates about 2.3 kJ/cm2 of radiation exposure energy for 10 minutes of stimulation time [20,21]. It emits an output or frequency modulated laser light of 40 mW per laser in wavelength. The treatment site was the masseter and the SCM. The masseter is the area connected widely between the zygomatic arch and the mandible, and the SCM spans from the sternum and clavicle to the mastoid process of the temporal bone [19].
The placebo was performed by attaching a laser pad after blocking the participant’s vision in the same way as other interventions.
The mouse opening (MO), pressure pain threshold (PPT), and stress were evaluated three times in total (baseline, post-test, and follow-up at 2 weeks).
In this study, TMJ maximal mouth opening was measured using the Therabite Range of Motion Scale (TRMS). TRMS was created for self-diagnosis of TMD patients, and is a ‘gold-standard’ grade measurement tool with high reliability of patient measurement reliability r=0.92 [22]. The median value was recorded by repeatedly measuring the maximum opening within the range of the participant’s active pain-free position in a comfortable lying position with a mm ruler at the interval between the median rows of the upper and lower teeth. The range of normal mouth opening is 40-50 mm.
In this study, the PPT was measured using a pressure pain gauge. As a pain measurement tool, each of the pain thresholds was measured at the painful site of the TMJ using a Commander Algometer (JTECH Medical Industries, Inc., Salt Lake City, UT, USA). The measuring instrument was placed vertically on the SCM and masseter muscles. The pressure was increased at a constant rate of 1 lb/sec, and made a “ah” beep when the pain began to be felt, and the pressure applied at that moment was measured as the tenderness threshold. To reduce the error, evaluation was performed 3 times at 1-minute intervals and average values were recorded. The intra-measure reliability is r=0.99 [23].
Stress is an emotional factor that can cause tension and illness. Among them, as a physiological reaction, the function of the cardiovascular system is enhanced, and sweating occurs. The secretory activity of the sweat glands can be measured by skin conductance, and the cardiovascular system is measured by heart rate. Stress measurement was performed using ProComp Infiniti (Thought Technology, Montreal, QC, Canada) [24]. The unit of skin conduction is micro suemens (
All statistical analysis was performed using IBM SPSS for Windows, Version 25.0 (IBM Co., Armonk, NY, USA). The homogeneity test used a chi-square test for categorical variables and one-way analysis of variance (ANOVA) for continuous variables. The main results were measured using a two-way repeated measures ANOVA to confirm the interaction between time and group. When there were significant differences, differences between groups were analyzed using a one-way ANOVA and Bonfferroni’s post-hoc test. In addition, partial eta square(
All 36 participants completed the study without withdrawing from the study (Figure 1). The general characteristics of participants are shown in Table 1, and there was no significant difference between groups (
As a result of MO, there were no statistically significant interactions according to the evaluation time point of each group (
As a result of PPT-masseter, there was a statistically significant interaction according to the evaluation time point of each group (
As a result of PPT-SCM, there was no statistically significant interactions according to the evaluation time point of each group (
As a result of stress-skin conductance, there were no statistically significant interactions according to the evaluation time point of each group (
As a result of the stress-heart rate, there were no statistically significant interactions according to the evaluation time point of each group (
TMD, which accounts for a large part of musculoskeletal pain, affects quality of life due to pain and limitation of chewing activity. Although studies on various treatment methods have been conducted, studies on the therapeutic effects of TENS and LLL, which are easy to apply and effective methods in clinical practice, are insufficient. Therefore, in this study, the effects of each treatment were compared and the effect of each treatment method was quantitatively analyzed through the application of a placebo.
As a result of this study, significant interaction between groups according to each evaluation time point was found in PPT-masseter (
In the MO results of this study, there was no significant difference between groups according to each evaluation point. As in this study, studies comparing TENS and LLL for TMJ also showed no significant difference [18,25]. Conversely, there was a study that showed a significant improvement in MO when applying LLL [19]. However, this is also a result that is consistent with the results analyzed through the effect size in this study. In addition, other studies used general LLL, and in this study, acupuncture-type LLL was used. This was similar to the average difference of 8 mm, similar to other previous studies [26].
In the PPT-masseter results of this study, there were significant differences between groups according to each evaluation time point (
In the stress results of this study, there was no significant difference between groups according to each evaluation point. In comparison through effect size, skin conductance had a post-intervention effect and a carryover effect as a moderate effect in the TENS group, and a post-intervention effect as a moderate effect in the TENS group and LLL group for heart rate. In the study of Monaco
As a limitation of this study, recruitment of participants was limited to universities and the sample size was small. In addition, the quality of life due to pain and dysfunction was attempted to be confirmed through stress, but precise analysis was difficult, and it is believed that TENS and LLL had somewhat different effects on the participant. This is because in the case of laser, the difference between the treatment duration and irradiated area may change, and in the case of TENS, the current delivered to the participant may cause great discomfort to some patients.
Therefore, in further studies, it is expected that discussion on the quality of life by recruiting a large number of participants in actual clinical practice is necessary, and it is necessary to restate each treatment effect by configuring the placebo in more detail.
It was conducted under the assumption that TMD-induced pain (PPT) causes dysfunction (MO) and affects stress (skin conductance and heart rate), and the effects of each treatment method (TENS, LLL, and placebo) were also compared.
LLL was most effective in pain control caused by TMD, and in the long term, TENS was also effective in pain control. In addition, the treatment effect of LLL was higher in the post-intervention effect compared to the placebo, and therefore, it can be said that it is effective for immediate functional improvement.
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
General characteristics of participants (N=36)
TENSG (n=12) | LLLG (n=12) | PG (n=12) | ||
---|---|---|---|---|
Age (y) | 23.50 (2.07) | 21.75 (2.86) | 21.58 (3.20) | 1.784 |
Sex (male/female) | 7/5 | 7/5 | 5/7 | 0.892 |
Height (cm) | 171.58 (7.22) | 169.67 (10.11) | 168.33 (11.74) | 0.329 |
Weight (kg) | 61.42 (9.03) | 66.00 (14.62) | 60.33 (11.48) | 0.762 |
BMI (kg/m2) | 20.76 (1.80) | 22.64 (2.79) | 21.08 (1.34) | 2.847 |
Values are presented as number only or mean (SD).
BMI: body mass index, TENSG: transcutaneous electrical nerve stimulation group, LLLG: low level laser group, PG: placebo group.
Results for each group according to the evaluation time point (N=36)
TENSG (n=12) | LLLG (n=12) | PG (n=12) | Time×Group | η2p | |
---|---|---|---|---|---|
Mouse opening (mm) | |||||
Baseline | 30.83 (4.37) | 33.61 (3.81) | 32.58 (2.69) | 1.972 | 0.107 |
Post-test | 37.17 (7.87) | 43.28 (2.30) | 38.69 (4.09) | ||
Follow-up at 2 weeks | 37.06 (7.28) | 39.72 (4.26) | 34.95 (6.19) | ||
Pressure pain threshold; masseter (lb) | |||||
Baseline | 3.49 (0.38) | 3.78 (0.80) | 3.74 (0.72) | 4.627* | 0.219 |
Post-test | 3.70 (0.35) | 4.67 (0.75)a | 3.57 (0.61) | ||
Follow-up at 2 weeks | 4.53 (0.84)b | 5.58 (1.24) | 4.03 (0.75) | ||
Pressure pain threshold; sternocleidomastoid (lb) | |||||
Baseline | 3.77 (0.55) | 4.51 (1.47) | 4.29 (1.91) | 2.005 | 0.108 |
Post-test | 4.33 (0.73) | 5.10 (0.60) | 3.89 (1.13) | ||
Follow-up at 2 weeks | 4.95 (0.47) | 5.39 (0.58) | 4.23 (1.21) | ||
Stress; skin conductance ( |
|||||
Baseline | 4.60 (2.09) | 3.85 (4.04) | 3.22 (2.47) | 6.532 | 0.119 |
Post-test | 3.32 (1.83) | 3.45 (2.59) | 2.53 (1.93) | ||
Follow-up at 2 weeks | 3.15 (2.10) | 4.88 (4.75) | 2.66 (1.76) | ||
Stress; heart rate (beat/min) | |||||
Baseline | 81.14 (11.00) | 93.94 (11.84) | 77.45 (20.99) | 0.390 | 0.023 |
Post-test | 74.95 (11.73) | 87.88 (12.32) | 74.43 (20.25) | ||
Follow-up at 2 weeks | 84.83 (27.69) | 92.19 (20.70) | 86.67 (18.77) |
Values are presented as mean (SD).
TENSG: transcutaneous electrical nerve stimulation group, LLLG: low level laser group, PG: placebo group.
a
*
Comparisons of the effect size for each intervention method using Cohen’s d (N=36)
Variables | Mouse opening | PPT-masseter | PPT-SCM | Stress-SC | Stress-HR |
---|---|---|---|---|---|
TENSG | |||||
aPe | 1.00 | 0.57 | 0.86 | 0.65 | 0.54 |
bCe | 1.04 | 1.58 | 2.31 | 0.69 | 0.18 |
LLLG | |||||
Pe | 3.07 | 1.14 | 0.53 | 0.12 | 0.50 |
Ce | 1.51 | 1.71 | 0.79 | 0.23 | 0.10 |
PG | |||||
Pe | 1.76 | 0.26 | 0.25 | 0.31 | 0.15 |
Ce | 0.50 | 0.39 | 0.04 | 0.26 | 0.46 |
Values are presented as effect size.
TENSG: transcutaneous electrical nerve stimulation group, LLLG: low level laser group, PG: placebo group, PPT: pressure pain threshold, PPT-SCM: pressure pain threshold-sternocleidomastoid, SC: stress-skin conductance, HR: heart rate.
aPe: post-intervention effect: post-test minus baseline.
bCe: carryover effect: follow-up at 2 weeks minus baseline.